Cholesterol-sphingomyelin interaction in membrane and apolipoprotein- mediated cellular cholesterol efflux

Journal of Lipid Research

Volumn 41, Issue 6, 2000, Pages 894-904

  Ito, Jin Ichi ^a   Nagayasu, Yuko ^a   Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Apolipoprotein; Cholesterol; HDL; Membrane; Sphingomyelin

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; SPHINGOMYELIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL INTERACTION; CELL MEMBRANE TRANSPORT; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FETUS; FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; RAT;

ANIMALS; APOLIPOPROTEIN A-I; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHOLESTEROL; RATS; SPHINGOMYELINS;

EID: 0033921028     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages: Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
2. Yokoyama, S. 1998. Apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta. 1392: 1-15.
3. Tsujita, M., and S. Yokoyama. 1996. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol. Biochemistry. 35: 13011-13020.
4. Bielicki, J. K., W. J. Johnson, R. B. Weinberg, J. M. Glick, and G. H. Rothblat. 1992. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J. Lipid Res. 33: 1699-1709.
5. Li, Q., M. Tsujita, and S. Yokoyama. 1997. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cholesterol efflux in macrophages. Biochemistry. 36: 12045-12052.
6. Li, Q., and S. Yokoyama. 1995. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat smooth muscle cells. J. Biol. Chem. 270: 26216-26223.
7. Brooks-Wilson, A., M. Marcil, S. M. Clee, I.-H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. F. Molhuizen, O. Loubser, B. F. F. Ouelette, K. Fichter, K. J. D. Ashbourne-Excoffon, C. W. Sensen, S. Schere, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. P. Kastelein, J. Genest, Jr., and M. R. Hayden. 1999. Mutations of ABC 1 in Tangier disease and familial high density lipoprotein deficiency. Nature Genetics. 22: 336-345.
8. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Böttcher, W. Diederich, W. Drobnik, S. Barlage, C. Büchler, M. Porsch-Özcürümez, W. E. Kaminski, H. W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K. J. Lackner, and G. Schmitz. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nature Genetics. 22: 347-351.
9. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J-C. Piette, J-F. Delueze, H. B. Brewer, N. Duverger, P. Denefle, and G. Assmann. 1999. Tangier disease is caused by mutations in the gene encoding ATP-cassette transporter 1. Nature Genetics. 22: 352-355.
10. Remaley, A. T., S. Rust, M. Rosier, C. Knapper, L. Naudin, C. Broccardo, K. M. Peterson, C. Koch, I. Arnould, C. Prades, N. Duverger, H. Funke, G. Assmann, M. Dinger, M. Dean, G. Chimini, S. Santaniariana-Fojo, D. S. Fredrickson, P. Denefle, and H. B. Brewer, Jr. 1999. Human ATP-binding cassette transporter 1 (ABC1): genornic organization and identification of the genetic defect in the original Tangier disease kindred. Proc. Natl. Acad. Sci. USA. 96: 12685-12690.
11. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, and J. F. Oram. 1999. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: R25-R31.
12. Ito, J., L. Zhang, M. Asai, and S. Yokoyama. 1999. Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes. J. Neurochem. 72: 2362-2369.
13. Wattenberg, B. W., and D. F. Silbert. 1983. Sterol partitioning among intracellular membranes. Testing a model for cellular sterol distribution. J. Biol. Chem. 258: 2284-2289.
14. van Blitterswijk, W. J., B. W. van der Meer, and H. Hilkmann. 1987. Quantitative contributions of cholesterol and the individual classes of phospholipids and their degree of fatty acyl (un)saturation to membrane fluidity by fluorescence polarization. Biochemistry. 26: 1746-1756.
15. Lund-Kazt, S., H. M. Laboda, L. R. McLean, and M. C. Phillips. 1988. Influence of molecular packing and phospholipid type on rates of cholesterol exchange. Biochemistry. 27: 3416-3423.
16. Brown, D. A., and J. K. Rose. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 68: 533-544.
17. Anderson, R. G. W. 1998. The caveolae membrane system. Ann. Rev. Biochem. 67: 199-225.
18. Slotte, J. P., G. Hesdröm, S. Rannström, and S. Ekman. 1989. Effects of sphingomyelin degradation on cell cholesterol oxidizability and steady-state distribution between the cell surface and the cell interior. Biochim. Biophys. Acta. 985: 90-96.
19. Pörn, M. I., and J. P. Slotte. 1995. Localization of cholesterol in sphingomyelinase-treated fibroblasts. Biochem. J. 308: 269-274.
20. Pörn, M. I., M. P. Ares, and J. P. Slotte. 1993. Degradation of plasma membrane phosphatidylcholine appears not to affect the cellular cholesterol distribution. J. Lipid Res. 34: 1385-1392.
21. Chatterjee, S. 1993. Neutral sphingomyelinase increases the binding, internalization, and degradation of low density lipoproteins and synthesis of cholesteryl ester in cultured human fibroblasts. J. Biol. Chem. 268: 3401-3406.
22. Slotte, J. P., and E. L. Bierman. 1988. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem. J. 250: 653-658.
23. Kato, T., J. Ito, K. Ishikawa, K. Mizutani, R. Tanaka, S. Wakabayashi, I. Horiuchi, K. Kato, and K. Kano-Tanaka. 1984. The absence of differentiation-promoting response of astroglioma cells to glia maturation factor. Brain Res. 301: 83-93.
24. Tajima, S., S. Yokoyama, and A. Yamamoto. 1983. Effect of lipid particle size on association of apolipoproteins with lipid. J. Biol. Chem. 258: 10073-10082.
25. Nishikawa, O., S. Yokoyama, and A. Yamamoto. 1986. A method for direct incorporation of radio-labeled cholesteryl ester into human low-density-lipoproteins: preparation of tracer substrate for cholesteryl ester transfer reaction between lipoproteins. J. Biochem. 99: 295-301.
26. Yokoyama, S., S. Tajima, and A. Yamamoto. 1982. The process of dissolving apolipoprotein A-I in an aqueous buffer. J. Biochem. 91: 1267-1272.
27. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
28. Thom, D., A. J. Powell, C. W. Lloyd, and D. A. Rees. 1977. Rapid isolation of plasma membranes in high yield from cultured fibroblasts. Biochem. J. 168: 187-194.
29. Francis, G. A., J. F. Oram, J. W. Heinecke, and E. L. Bierman. 1996. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry. 35: 15188-15197.
30. Härmäla, A-S., I. Pörn, P. Mattjus, and J. P. Slotte. 1994. Cholesterol transport from plasma membranes to intracellular membranes is inhibited by 3β-[2-(diethylanino)ethoxy]androst-5-en-17-one. Biochim. Biophys. Acta. 1211: 317-325.
31. Skiba, P. J., X. Zha, F. R. Maxfield, S. L. Schissel, and I. Tabas. 1996. The distal pathway of lipoprotein-induced cholesterol esterificalion, but not sphingomyelinase-induced cholesterol esterification is energy-dependent. J. Biol. Chem. 271: 13392-13400.
32. Underwood, K. W., N. L. Jacobs, A. Howley, and L. Liscum. 1998. Evidence for a cholesterol transport pathway from lysosomes to endoplasmic reticulum that is independent of the plasma membrane. J. Biol. Chem. 273: 4266-4274.
33. Ohvo, H., C. Olsio, and J. P. Slotte. 1997. Effects of sphingomyelin and phosphatidylcholine degradation on cyclodextrin-mediated cholesterol efflux in cultured fibroblasts. Biochim. Biophys. Acta. 1349: 131-141.
34. Slotte, J. P., J. Tenhunen, and I. Pörn. 1990. Effects of sphingomyelin degradation on cholesterol mobilization and efflux to high-density lipoproteins in cultured fibroblasts. Biochim. Biophys. Acta. 1025: 152-156.